MCLAREN GREATER LANSING — History
CCN 230167 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$384M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
-9.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $332M | $374M | $384M | +2.6% | +7.5% |
| Operating Expenses | $356M | $382M | $422M | +10.5% | +8.9% |
| Operating Margin | -7.1% | -2.0% | -9.8% | -402.5% | +0.0% |
| Net Income | $-23M | $-7M | $-38M | -415.5% | +0.0% |
| Licensed Beds | 237 | 237 | 185 | -21.9% | -11.6% |
| Total Patient Days | 44,775 | 49,292 | 53,023 | +7.6% | +8.8% |
| Medicare Day % | 34% | 26% | 21% | -19.0% | -20.9% |
| Medicaid Day % | 12% | 8% | 5% | -30.5% | -32.7% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +15.6% ($332M → $384M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-9.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $410M | -11.2% |
| FY2024 (proj) | $436M | -12.5% |
| FY2025 (proj) | $462M | -13.9% |